
USA approves new drug for Alzheimer’s disease in 20 years
The new treatment for Alzheimer’s disease has been approved by the regulators of USA nearly after 20 years. This approval will trigger pressure to make it available worldwide despite of its mixed evidence over its efficacy. Aducanumab targets the Underlying cause of Alzheimer’s, the most common form of dementia. Food and Drug Administration (FDA) of […]







